Adductor Canal Block for Total Knee Arthroplasty

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions
Arthroplasty, Replacement, KneePain, Postoperative
Interventions
PROCEDURE

Adductor Canal Block

Following negative aspiration, SSACNB volume will be randomized and subjects will receive 5, 10 or 20 ml of 0.5% bupivacaine will be incrementally injected. Randomization of the volume of bupivacaine will be determined by opening a sequential, pre-sealed envelope with the group assignment designated within. All studied volumes are well within the acceptable range for SSACNB.

DRUG

Adductor Canal Block

Following negative aspiration, SSACNB volume will be randomized and subjects will receive 5, 10 or 20 ml of 0.5% bupivacaine will be incrementally injected. Randomization of the volume of bupivacaine will be determined by opening a sequential, pre-sealed envelope with the group assignment designated within. All studied volumes are well within the acceptable range for SSACNB.

Trial Locations (1)

53792

University of Wisconsin School of Medicine and Public Health, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT02453360 - Adductor Canal Block for Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter